Please note: In October and November 2010, the MHRA moved from its Market Towers address to a new location on Buckingham Palace Road. Please go to the contact us section of the website for updated contact details.
DRUG ALERT
CLASS 3 MEDICINES RECALLFor distribution to hospitals, wholesalers and relevant clinics
| 05 January 2010 | EL (10)A/01 | Our ref: MDR 45-12/09 |
Dear Healthcare Professional,
Aurum Pharmaceuticals
Amiodarone Hydrochloride 50 mg/ml Concentrate
| Batch Number | Expiry Date | Pack Size | First Distributed |
| 80593 | 09/2010 | 10 ampoules | 30/10/2008 |
| 80604 | 12/2010 | 10 ampoules | 17/4/2009 |
Following our Class 4 Caution in Use notice issued on 23 December 2009 (EL (09)A/36) and further discussions with Aurum Pharmaceuticals, all remaining stock of the above two batches is now being recalled from hospitals, wholesalers and relevant clinics.
For medical information enquiries please contact Aurum Pharmaceuticals medical information on 01708 382791. For enquiries relating to stock returns and credit please contact Aurum Pharmaceuticals customer services on 0800 028 7933.
Recipients of this Drug Alert are requested to bring it to the attention of relevant professionals by copy of this letter. Primary Care Trusts are asked to forward this to listed recipients, and relevant clinics and not to GPs and Community Pharmacists unless known to be relevant.
Yours faithfully
Ian Holloway
DMRC Manager
Regional contacts for NHS trusts and provider units
Chief pharmacists: England, Scotland, Wales, Northern Ireland
Prison Health Policy Unit (DH)
Chief pharmacists: Jersey, Guernsey, Alderney, Sark, Isle of Man, Gibraltar
Special hospitals
Healthcare Commission for distribution to independent health care establishments
Primary care trusts (England)
Class 3 Drug Alert (Action within 5 days): Aurum Pharmaceuticals - Amiodarone Hydrochloride 50 mg/ml Concentrate - EL (10)A/01 
